Research News and Research

RSS

University of Houston and Texas Instruments collaborate to simplify development of new portable applications

From smart phones to medical equipment, embedded processors are everywhere and getting increasingly more powerful. One University of Houston (UH) professor's work with Texas Instruments (TI) is making it easier to develop these types of systems.

7 Aug 2010

American Psychological Association 2010 meeting to feature new research into same-sex couples' relationships

The American Psychological Association's 2010 meeting will include a full program of sessions summarizing the areas of research that have been key in recent same-sex marriage court cases and other legal decisions supporting equality for lesbian, gay, bisexual and transgender people. Sessions will feature the latest scientific research into same-sex couples' relationships and family formation among lesbian, gay and bisexual people,

7 Aug 2010

SecureWorks cited leader in managed security services by Forrester

Atlanta-based SecureWorks®, Inc., a leading global provider of security services protecting 2,900 clients worldwide, announced today that the company was one of only two "leaders" cited in The Forrester Wave™: Managed Security Services, Q3 2010 report (August 2010). SecureWorks was among 11 select Managed Security Services (MSS) providers that Forrester Research, Inc. invited to participate in the study.

7 Aug 2010

45-year-old Hummelstown patient takes on FDA over Johnson & Johnson’s antibiotic Levaquin

Suffering from injuries to his brain, nerves, and tendons for over four years, 45-year-old John Fratti of Hummelstown, PA, has taken on the Food and Drug Administration with good results. Since taking Johnson & Johnson’s antibiotic Levaquin for an infection he has had many diagnostic studies on his brain and body that show considerable damage. Healthy and athletic at 41 years of age, he now takes multiple prescription pain medications for his injuries.

7 Aug 2010

EpiCept second-quarter net loss decreases to $4.9 million

EpiCept Corporation today announced operating and financial results for the three and six months ended June 30, 2010, and provided an update with respect to the Company's key business initiatives.

7 Aug 2010

Hospital revenue cycle leaders establish protocols for responding to RACs

Most hospital revenue cycle leaders have established protocols for responding to Revenue Audit Contractors, as well as post-payment audits targeting Medicaid and commercial claims. Mindful of the dollars at stake, these leaders have employed a number of technology and process-related improvements to mitigate risk and solidify overall revenue integrity.

7 Aug 2010

ADVENTRX second-quarter net loss applicable to common stock increases to $5.0 million

ADVENTRX Pharmaceuticals, Inc. today reported financial results for the three and six months ended June 30, 2010.

7 Aug 2010

Taiyo Pacific Partners becomes third largest shareholder in CMIC

Taiyo Pacific Partners announced today that it has accumulated a position in excess of 5% in CMIC Co., Ltd. (2309) to become its third largest shareholder. Taiyo Pacific Partners is known for its cooperative investment style working with senior management to enhance shareholder value.

7 Aug 2010

Opexa Therapeutics aims to complete planned experiments, develop clinical study protocols

Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the quarter ended June 30, 2010 and provided an update on its corporate developments.

7 Aug 2010

MedQuist contributes to new industry standard measurement policy for transcription jobs

MedQuist Inc., a leading provider of technology-enabled clinical documentation services, continues to support industry best practices for quality standards and metrics. Together with the American Health Information Management Association (AHIMA), the Association for Healthcare Documentation Integrity (AHDI), the Medical Transcription Industry Association (MTIA) and other industry quality leaders, MedQuist contributed to the new Healthcare Documentation Quality Assessment and Management Best Practices just unveiled at the AHDI 32nd Annual Convention and Expo.

7 Aug 2010

Ardea Biosciences second-quarter total revenues decline to $3.5 million

Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2010.

7 Aug 2010

Researchers examine differences in eating habits of African Americans

Researchers looking for differences in eating habits of African Americans based on whether or not they had Type 2 diabetes uncovered an unexpected result: No matter what the blood sugar level was, the dietary intakes were pretty much the same.

7 Aug 2010

Orexigen second-quarter net loss decreases to $11.9 million

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.

7 Aug 2010

BioSpecifics Technologies second-quarter total revenues decrease to $0.9 million

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the second quarter ended June 30, 2010. The Company's partner, Auxilium Pharmaceuticals, Inc. markets XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.

7 Aug 2010

Omnicare second-quarter earnings per diluted share decrease to 18 cents

Omnicare, Inc., one of the nation's leading providers of pharmaceutical care for the elderly, reported today financial results for its second quarter ended June 30, 2010.

7 Aug 2010

Halozyme second-quarter revenue increases to $3.2 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the second quarter ended June 30, 2010.

7 Aug 2010

Shlomo Melmed appointed to Independent Citizen's Oversight Committee

Shlomo Melmed, M.D., senior vice president for academic affairs and dean of the medical faculty at Cedars-Sinai Medical Center, has been appointed by Gov. Arnold Schwarzenegger to the Independent Citizen's Oversight Committee, the governing board of the California Institute for Regenerative Medicine.

7 Aug 2010

Study generates promising data about sustained durability of Zyclara's efficacy versus cryosurgery alone

Results from a randomized study with Zyclara following cryotherapy in the treatment of actinic keratoses (AK) demonstrated Zyclara complemented the effectiveness of cryosurgery in reducing total AK count and achieving complete clearance of AK, according to data presented at the American Academy of Dermatology Summer Academy Meeting 2010 (Summer AAD), August 4 - 8.

7 Aug 2010

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

The U.S. Senate last night passed the "Improving Access to Clinical Trials Act" (I-ACT), a bipartisan piece of legislation championed by the Cystic Fibrosis Foundation, its advocates and 120 other health advocacy organizations.The legislation enables patients with rare diseases to participate in clinical trials without losing eligibility for public healthcare benefits.

7 Aug 2010

NeurogesX net loss for second-quarter 2010 increases to $10.2 million

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today reported results for its second quarter ended June 30, 2010.

7 Aug 2010

Research News and Research

University of Houston and Texas Instruments collaborate to simplify development of new portable applications

American Psychological Association 2010 meeting to feature new research into same-sex couples' relationships

SecureWorks cited leader in managed security services by Forrester

45-year-old Hummelstown patient takes on FDA over Johnson & Johnson’s antibiotic Levaquin

EpiCept second-quarter net loss decreases to $4.9 million

Hospital revenue cycle leaders establish protocols for responding to RACs

ADVENTRX second-quarter net loss applicable to common stock increases to $5.0 million

Taiyo Pacific Partners becomes third largest shareholder in CMIC

Opexa Therapeutics aims to complete planned experiments, develop clinical study protocols

MedQuist contributes to new industry standard measurement policy for transcription jobs

Ardea Biosciences second-quarter total revenues decline to $3.5 million

Researchers examine differences in eating habits of African Americans

Orexigen second-quarter net loss decreases to $11.9 million

BioSpecifics Technologies second-quarter total revenues decrease to $0.9 million

Omnicare second-quarter earnings per diluted share decrease to 18 cents

Halozyme second-quarter revenue increases to $3.2 million

Shlomo Melmed appointed to Independent Citizen's Oversight Committee

Study generates promising data about sustained durability of Zyclara's efficacy versus cryosurgery alone

U.S. Senate passes I-ACT to enable patients with rare disease to participate in clinical trials

NeurogesX net loss for second-quarter 2010 increases to $10.2 million

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence